MIMETAS is a leading company in the field of 3D disease modeling, providing unmatched disease relevance, precision, and throughput. The company is dedicated to leveraging its 3D tissue expertise to offer tailored solutions for unique research questions in drug discovery and compound analysis.

We strive to contribute to groundbreaking therapies with ourscreenable, physiologically relevant 3D human disease models. By combining technological strengths and expertise, we establish strong drug development partnerships with and offer services to global pharmaceutical companies to develop innovative therapies to target untreatable diseases. For more information, visit: www.mimetas.com.

EASME - EU Executive Agency for SMEs

Zeeuws Investerings Fonds

Aglaia BioMedical Ventures

Cathay Venture

COM:MIMETAS

MIMETAS

Analysis Not Available